• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂通过激活ERK通路促进A549人肺腺癌细胞中PD-L1的表达

[Cisplatin promotes PD-L1 expression in A549 human lung adenocarcinoma cells via activating the ERK pathway].

作者信息

Zhu Hong, Liu Dan, Deng Shukai

机构信息

Department of Respiration, First Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.

Department of Respiration, First Affiliated Hospital of Southwest Medical University, Luzhou 646000, China. *Corresponding author, E-mail:

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2021 Oct;37(10):891-896.

PMID:34670665
Abstract

Objective To investigate the effect of cisplatin (DDP) on the expression of programmed death 1 ligand 1 (PD-L1) in human lung adenocarcinoma A549 cells and its possible mechanism. Methods Human lung adenocarcinoma A549 cells were cultured in vitro and treated with (0, 0.5, 1, 2, 4, 8) mg/L of DDP for 24, 36, 48 hours. CCK-8 assay was used to detect the cell proliferation inhibition rate and the half maximal inhibitory concentration (IC) was calculated. The optimal inhibition time of 48 hours and its IC were selected for subsequent experiments. A549 cells were then randomized into four groups: blank control group, group with DDP (IC), group with 20 μmol/L of mitogen-activated protein kinase kinase inhibitor PD98059, and group with DDP (IC) combined with 20 μmol/L of PD98059. The cells were cultured for 48 hours. The expression of ERK and p-ERK were detected by Western blotting, and PD-L1 expression was detected by flow cytometry. Results Compared with that in the control group, the expression of PD-L1 in A549 cells treated with DDP was up-regulated in a dose-dependent manner. The optimal time was 48 hours and the IC was 3.586 mg/L. Also compared with that in the control group, the expression of p-ERK and PD-L1 in the DDP treatment group increased, and the expression of p-ERK in the group with PD98059 decreased. The expressions of p-ERK and PD-L1 in the group with DDP combined with PD98059 were lower than those in the group with DDP, but higher than those in the group with PD98059. Conclusion DDP up-regulates the expression of PD-L1 in A549 cells by activating the ERK signaling pathway.

摘要

目的 探讨顺铂(DDP)对人肺腺癌A549细胞程序性死亡1配体1(PD-L1)表达的影响及其可能机制。方法 体外培养人肺腺癌A549细胞,分别用(0、0.5、1、2、4、8)mg/L的DDP处理24、36、48小时。采用CCK-8法检测细胞增殖抑制率并计算半数抑制浓度(IC)。选取48小时的最佳抑制时间及其IC用于后续实验。然后将A549细胞随机分为四组:空白对照组、DDP(IC)组、20 μmol/L丝裂原活化蛋白激酶激酶抑制剂PD98059组、DDP(IC)联合20 μmol/L PD98059组。细胞培养48小时。采用蛋白质印迹法检测ERK和p-ERK的表达,采用流式细胞术检测PD-L1表达。结果 与对照组相比,DDP处理的A549细胞中PD-L1的表达呈剂量依赖性上调。最佳时间为48小时,IC为3.586 mg/L。同样与对照组相比,DDP处理组中p-ERK和PD-L1的表达增加,PD98059组中p-ERK的表达降低。DDP联合PD98059组中p-ERK和PD-L1的表达低于DDP组,但高于PD98059组。结论 DDP通过激活ERK信号通路上调A549细胞中PD-L1的表达。

相似文献

1
[Cisplatin promotes PD-L1 expression in A549 human lung adenocarcinoma cells via activating the ERK pathway].顺铂通过激活ERK通路促进A549人肺腺癌细胞中PD-L1的表达
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2021 Oct;37(10):891-896.
2
Arsenic sulfide reverses cisplatin resistance in non-small cell lung cancer in vitro and in vivo through targeting PD-L1.砷化硫通过靶向 PD-L1 在体外和体内逆转非小细胞肺癌对顺铂的耐药性。
Thorac Cancer. 2021 Oct;12(19):2551-2563. doi: 10.1111/1759-7714.14136. Epub 2021 Sep 1.
3
Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.阿帕替尼通过逆转多药耐药并抑制 ERK 信号通路使顺铂耐药非小细胞肺癌 A549 细胞重新敏感。
Eur Rev Med Pharmacol Sci. 2017 Dec;21(23):5370-5377. doi: 10.26355/eurrev_201712_13922.
4
[The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].海参糖胺聚糖联合顺铂对人肺腺癌A549细胞增殖及化疗反应的作用
Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):252-257. doi: 10.3760/cma.j.issn.0253-3766.2018.04.003.
5
C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells.C-Myc参与A549/DDP肺腺癌细胞中β-连环蛋白介导的耐药性。
APMIS. 2014 Dec;122(12):1251-8. doi: 10.1111/apm.12296. Epub 2014 Aug 6.
6
Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.抑制微小RNA-196a可能会逆转A549/DDP非小细胞肺癌细胞系的顺铂耐药性。
Tumour Biol. 2016 Feb;37(2):2387-94. doi: 10.1007/s13277-015-4017-7. Epub 2015 Sep 16.
7
[Synergistic Antitumor Effect of Amorphigenin Combined with Cisplatin in Human Lung Adenocarcinoma A549/DDP Cells].[知母皂苷元联合顺铂对人肺腺癌A549/DDP细胞的协同抗肿瘤作用]
Zhongguo Fei Ai Za Zhi. 2016 Dec 20;19(12):805-812. doi: 10.3779/j.issn.1009-3419.2016.12.02.
8
XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.XPC 抑制通过 Akt/mTOR 信号通路拯救 A549/DDP 肺腺癌细胞中的顺铂耐药性。
Oncol Rep. 2019 Mar;41(3):1875-1882. doi: 10.3892/or.2019.6959. Epub 2019 Jan 9.
9
LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.长链非编码 RNA NNT-AS1 通过 MAPK/Slug 通路成为非小细胞肺癌顺铂化疗耐药的主要介质。
Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4879-4887. doi: 10.26355/eurrev_201808_15624.
10
[Increased expression of acetaldehyde dehydrogenase in cisplatin-resistant human lung adenocarcinoma A549/DDP cells].[顺铂耐药人肺腺癌A549/DDP细胞中乙醛脱氢酶表达增加]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 May;31(5):625-9.

引用本文的文献

1
Metformin induces apoptosis in pituitary-derived folliculostellate cells via the IL-6/ERK pathway.二甲双胍通过IL-6/ERK途径诱导垂体来源的滤泡星状细胞凋亡。
Discov Oncol. 2025 Apr 24;16(1):598. doi: 10.1007/s12672-025-02372-y.